Less than half of trials on clinicaltrials.gov meet the FDAAA results reporting deadline in a study from Ben Goldacre’s EBM DataLab at Oxford University
[VIDEO] Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment
Gemma Rogers, Communications Director at Oxford Pharmagenesis, discusses a study on clinical trial transparency.
Missed ISMPP EU 2019? Read our meeting report to get up to speed!
Is your institute breaking European clinical trial reporting rules? Find out using the new EU trials tracker, part of the AllTrials initiative.
A new, regular series in The BMJ will highlight a different unreported clinical trial every week, with the intention of improving reporting rates.
The FDAAA 2007 requires clinical trials to make results publicly available 12 months after study completion. A new tool from TrialsTracker provides a live online report on compliance.